ERcast: Clinical Perspectives Podcast Preview
Hippo ERcast December 2024
- Dec 2024
- 10 Chapters
- 2 hr 53 min
Welcome to the December 2024 Edition of ERcast! This month we are celebrating 15 years of ERcast and we are kicking off this episode with DeLaney who reflects on changes in Emergency Medicine and in his own career over the past 15 years. Dr. Jeff Tabas joins Drew Kalnow to discuss a structured approach to decision-making post-ROSC and Chris Hicks talks with Drew Kalnow about the nuances of using Massive Hemorrhage Protocols. Ilene Claudius and Andy Little sit down to share recommendations for the treatment of both diarrhea and constipation in children. Andy and Jess Pescatore, a clinical pharmacist and toxicologist, walk us through managing salicylate toxicity with bicarb drips and advise on when to consider dialysis. DeLaney and Brit Long help us distinguish between pre-septal cellulitis and orbital cellulitis and Christina Shenvi talks with ENT surgeon Justin Miller about how to diagnose and manage PTAs. Lit Matters with Cam and Drew is all about Holiday dinner - benefits and harms! Let’s get started!
Faculty
- Andy Little, DO
Dr. Andy Little is an emergency medicine physician and educator. He earned his medical degree from the Ohio University Heritage College of Osteopathic Medicine and completed his emergency medicine residency at OhioHealth Doctors Hospital Emergency Medicine Residency, where he served as Chief Resident. He has received multiple national awards, including recognition from the American Osteopathic Association, American College of Osteopathic Emergency Physicians, and Emergency Medicine Residents' Association.
- Cameron Berg, MD
Based in Minneapolis, MN, Dr. Berg focuses on simplifying complex patient care processes, such as chest pain, syncope, and heart failure treatment. Since 2020, he has also been navigating his own recovery from a TBI after a bicycle accident. When he isn't in the clinic, Cameron is usually busy keeping his three young children alive and happy.
- Christina Shenvi, MD, PhD
Dr. Christina Shenvi is a Professor of Emergency Medicine at the University of North Carolina at Chapel Hill School. She is fellowship-trained in geriatric emergency medicine and is the creator and host of GEMCAST, a podcast focused on geriatric EM. Dr. Shenvi has served on the Board of Governors for the ACEP Geriatric ED accreditation. A passionate educator, she has received multiple institutional and national teaching awards and co-directs the ACEP Teaching Fellowship. Her academic interests include teaching and learning, deliberate practice, and innovative pedagogy.
- Drew Kalnow, DO
Dr. Drew Kalnow is an emergency medicine physician and educator based in Columbus, Ohio. He completed his emergency medicine training at OhioHealth Doctors Hospital Emergency Medicine Residency. Dr. Kalnow is passionate about advancing emergency medicine through high-quality education, with a particular focus on simulation, learning theory, and innovative teaching.
- Matthew DeLaney, MD, FACEP, FAAEM
Dr. Matthew DeLaney is an emergency medicine physician and educator based in Birmingham, Alabama. A native of Mobile, he earned his medical degree from the University of South Alabama and completed his emergency medicine residency at Maine Medical Center.Dr. DeLaney has experience in both community and academic emergency medicine and is known for his commitment to teaching and medical education. He lives in Birmingham with his wife, Erin, who is also a physician, and their two daughters.
- Brit Long, MD
Dr. Brit Long is a Professor of Emergency Medicine at the University of Virginia and an emergency medicine physician with experience in both a community ED and at a military academic center ED. He is the Clinical Editor-in-Chief of emDOCs.His professional interests include medical education, evidence-based medicine, and the FOAMed movement. Outside of work, he enjoys spending time with his wife and two daughters
- Chris Hicks, MD
Chris Chris Hicks is an emergency physician, trauma team leader, educator, and speaker with expertise in resuscitation, simulation, and psychological performance in healthcare. His work has focused on areas such as mental practice, stress inoculation training, and improving team performance in high-stakes clinical environments. He has contributed to the development of interprofessional and simulation-based medical education initiatives and has collaborated with healthcare organizations on the design of systems, spaces, and teams to support high-performance care delivery. Chris is also a longtime supporter of the FOAMed movement and is widely recognized for his engaging and practical approach to medical education. Outside of medicine, he enjoys running, cycling, boxing, music, and spending time with his family.
- Jess Rivera Pescatore, PharmD
Dr. Rivera earned her PharmD from the University of Florida. She completed a pharmacy practice residency at Lakeland Regional Health in Lakeland, Florida in 2011 and went on to complete a Clinical Toxicology/Emergency Medicine Fellowship with the Florida Poison Information Center at UF Health Jacksonville in Jacksonville, Florida. For the past 6 years, Dr. Rivera has practiced as a Clinical Pharmacist in Emergency Medicine at UAB Hospital in Birmingham, Alabama where she is an Associate Professor with the Department of Emergency Medicine. She is board-certified as a Diplomate of the American Board of Applied Toxicology and serves her institution’s Office for Medical Toxicology and the Alabama Poison Information Center as a Clinical Toxicologist
- Jeffrey Tabas, MD
- Ilene Claudius, MD
- Justin Miller, MD
Chapters
Celebrating 15 years of ERcast
Emergency medicine has changed fast over the last 15 years: chest pain risk stratification matured with the HEART score, DOACs moved from nonexistent to routine, and overdose and COVID reshaped everyday practice. Career satisfaction changed too, as many physicians moved from chasing the "perfect" job toward a clearer personal North Star. How Emergency Medicine Has Changed Chest pain risk stratification: The HEART score changed ED chest pain evaluation by giving clinicians a practical framework for short-term risk, a major shift from the pre-2008 era when this approach did not exist. DOAC adoption curve: Direct oral anticoagulants went from nonexistent in 2010 to standard therapy in everyday emergency care, a useful marker of how quickly novel treatments become routine. Overdose crisis evolution: Opioid overdose deaths began climbing in 2011, and the emergency response has evolved alongside the epidemic as recognition, harm-reduction thinking, and frontline workflows changed. COVID practice disruption: COVID altered both what emergency clinicians treat and how they deliver care, with operational changes that still shape staffing, flow, and bedside interactions. We get into that broader arc in the episode. Workforce pressure points: Corporate group employment and expansion in residency positions reflect a workforce landscape that feels increasingly strained, with implications for hiring, autonomy, and long-term career stability. Career Meaning and Professional Priorities Early career metrics: Early priorities often center on high-acuity resuscitations, hourly pay, and the search for a unicorn job, but those goals can turn low-acuity care and schedule friction into chronic frustration. Low acuity patient lens: Low-acuity patients still need emergency physicians; reframing the visit as a significant life event rather than ED misuse can improve empathy and day-to-day job satisfaction. Money versus enough: A healthier financial frame is asking what income is actually needed to meet goals, then protecting time for life outside work instead of reflexively maximizing shifts. The perfect job myth: There may not be one perfect emergency medicine job, and treating work as transactional helps explain why crowding, boarding, pay cuts, and staffing problems hit so hard. Finding a North Star: A durable career anchor is not salary or prestige but a personal guiding purpose; here, it is the simple idea of trying to make people feel better. That distinction is worth hearing in the episode.
Tabas Talks: When to Activate the Cath Lab After ROSC
ST-segment elevation after return of spontaneous circulation is a clear trigger for immediate cath lab activation. Post-ROSC coronary angiography without ST elevation is different: randomized trials do not support a routine emergent approach unless ongoing ischemia, shock, or electrical instability changes the picture. Cath Lab Decisions After ROSC ST elevation after ROSC: Persistent or transient ST-segment elevation after ROSC should prompt cath lab activation without hesitation, because 70-80% of VF/pVT cases have an acute thrombotic culprit lesion. No STE default strategy: Absent ST elevation, routine emergent angiography is not recommended after ROSC; COACT, TOMAHAWK, and later meta-analysis found no neurologic survival benefit from rushing every patient to the lab. NSTEMI high-risk exceptions: NSTEMI still goes urgently when the patient has refractory ischemic pain, cardiogenic shock, or electrical instability. We walk through that decision frame in the episode. Refractory VF or pVT: Ongoing or recurrent VF/pVT after prolonged ACLS is a different signal, with acute thrombotic lesions seen in roughly 60-65% of cases even when the post-ROSC ECG lacks ST elevation. If cath is unavailable: When a true post-ROSC STEMI cannot get immediate catheterization, thrombolytics are the fallback reperfusion strategy while definitive transfer planning proceeds. Immediate post-ROSC care: If the lab is not activated right away, serial ECGs, blood pressure optimization, targeted temperature management, and early cardiology contact anchor the next phase of care.
Holiday Dinner Lit Matters 1: Chew Your Food!
Esophageal food impaction is a time-sensitive emergency, with complete obstruction generally needing removal within 6 hours and partial obstruction within 24 hours. In adults with suspected soft food bolus impaction, cola appears safe but performs no better than observation for symptom improvement or passage. Esophageal Food Impaction Evidence Time-sensitive obstruction window: Complete esophageal obstruction warrants urgent removal within 6 hours, while partial impaction can wait up to 24 hours, a practical distinction that frames when bedside tricks are reasonable. Typical impaction presentation: The studied patients had sudden foreign-body sensation during swallowing and inability to handle saliva, a high-yield bedside picture for soft food bolus impaction rather than sharp-object ingestion. Cola trial bottom line: In a multicenter randomized trial, cola was safe but not effective: symptom improvement was 61% in both the cola and no-treatment groups. Spontaneous passage reality: A meaningful share of impactions passed while patients were simply observed, underscoring that apparent success after cola may reflect time rather than a true treatment effect. Adverse event signal: No major adverse events were attributed to cola, though several patients developed abdominal discomfort, so its main appeal is low apparent harm rather than clear efficacy. We get into how that shapes real-world ED practice in the episode. Glucagon-level disappointment: Common ED remedies such as cola and glucagon look more like tradition than therapy, so the decisive intervention remains endoscopy when obstruction persists or high-risk features are present.
Massive Hemorrhage Protocol: Change a Word, Shift a Paradigm
Traumatic hemorrhage is more than a transfusion problem; it is a time-critical systems problem spanning activation, hemostatic resuscitation, monitoring, and stopping rules. Massive hemorrhage protocol reframes trauma resuscitation around coordinated team action, early coagulopathy control, and explicit triggers for escalation. Massive Hemorrhage Protocol in Trauma Paradigm shift in trauma: Massive hemorrhage protocol moves beyond the classic ≥10-unit massive transfusion definition and treats exsanguinating trauma as a multidisciplinary resuscitation problem, not just a blood delivery task. Standardized activation triggers: Early activation works best when the trigger is preset rather than ad hoc, using tools like the ABC score, shock index, or a critical administration threshold. We walk through how to build that trigger in the episode. Balanced component therapy: Blood products should be delivered in a balanced institutional ratio, and centers without FFP can substitute adjuncts such as prothrombin complex concentrate plus fibrinogen concentrate. TXA simplification strategy: Tranexamic acid has shifted from the old split-dose CRASH-2 approach toward a single 2 g IV strategy, with timing in the first hours of care mattering more than elegant choreography. Hourly coagulation reassessment: Repeat labs every hour with emphasis on coagulation studies and fibrinogen, because trauma kills through both injury-driven and resuscitation-induced coagulopathy more than a hemoglobin number alone. Seven T operational framework: The 7 T's give MHP a usable structure: triggers, team preparation, tranexamic acid, testing, transfusing to target, temperature management, and termination. The operational sequencing is worth hearing in the chapter.
Why We Don't Give That to Kids With Diarrhea or Constipation
Pediatric diarrhea is treated first with hydration and skin protection, not antimotility drugs. Pediatric constipation also rewards restraint: diet and age-appropriate bowel regimens are usually safer than repeated enemas, while a few familiar medications carry important age cutoffs and electrolyte risks. Pediatric Diarrhea Treatment Pearls Hydration first approach: Oral rehydration is the mainstay, with about 10 mL/kg used to replace ongoing diarrheal losses; low-sugar fluids matter because sugary drinks can worsen stool output. Skin protection matters: Diaper dermatitis prevention is part of treatment, not an afterthought; frequent changes and generous barrier cream use can materially reduce pain and return visits. Reassurance for anxious parents: New-onset diarrhea often needs clear counseling more than medication, especially when parents are worried; explaining why antidiarrheals can cause harm changes the conversation. Diphenoxylate atropine warning: Diphenoxylate/atropine is not indicated in children under 6 because opioid and anticholinergic effects can produce CNS depression, respiratory compromise, and ileus. Loperamide safety concerns: Loperamide is not recommended in children under 2 and deserves caution under 6; beyond constipation and ileus, it has been linked to torsades and misuse. We get into the practical counseling language in the episode. Pediatric Constipation Medication Safety Diet before bowel meds: Dietary measures are the first step for most children with constipation, while medication choice depends heavily on age and stool history rather than reflex escalation. Normal stooling can vary: Constipation histories are tricky in children, and neonates may go several days without a bowel movement, a useful reminder before labeling normal variation as disease. Enema frequency limit: More is not better with enemas; children should not receive more than one enema in 24 hours because complications rise quickly when families repeat dosing at home. Sodium phosphate caution: Sodium phosphate enemas have strict age-based volumes and should not be used under age 2; hyperphosphatemia can precipitate clinically important hypocalcemia. We walk through the age cutoffs in the chapter. Safer oral and rectal options: Glycerin suppositories, polyethylene glycol, magnesium citrate, and mineral oil can all be appropriate in selected children, but each has age exceptions and dosing nuances that matter.
Tox Consult: When to Use Bicarb Drips and Dialysis
Salicylate poisoning is a pH-driven emergency where bicarbonate works by alkalinizing serum and urine, not by serving as a passive “drip and forget” antidote. Dialysis becomes critical when levels are high, the patient is deteriorating, or pulmonary edema makes alkalinization unsafe. Salicylate Bicarbonate and Dialysis pH-driven salicylate trapping: Bicarbonate helps by ionizing salicylate so it stays out of the brain and is excreted in urine; the practical serum and urine pH targets are a key bedside anchor. potassium-dependent alkalinization: Hypokalemia can quietly defeat urine alkalinization, which is why empiric potassium with each liter of bicarbonate-containing fluid is a recurring tox pearl we explain in the episode. dialysis escalation triggers: Dialysis should be on the table for salicylate levels above 100 mg/dL, above 90 mg/dL with renal impairment, and for lower levels when the patient is clinically decompensating. pulmonary edema exception: Pulmonary edema is a major red flag because these patients may not tolerate the fluid load needed for bicarbonate therapy, making extracorporeal removal the safer path. post-dialysis rebound risk: Salicylate levels can rise again after hemodialysis, so repeat labs matter and some patients need additional sessions rather than assuming one run is definitive. When Bicarb Helps in Toxicology mechanism-first bicarb thinking: Sodium bicarbonate is a nonspecific antidote only in the right mechanism: either you need an exogenous sodium load for cardiotoxicity or alkalinization to change drug ionization. sodium channel blockade clue: A wide QRS is the bedside sign that points toward myocardial sodium channel blockade; in TCA exposure, a QRS over 100 msec is a concerning threshold. bolus not passive infusion: For sodium channel-blocking cardiotoxicity, bicarbonate starts as a bolus aimed at QRS narrowing, not as a maintenance drip that lulls the team into false reassurance. alkalinization for weak acids: Salicylate, phenobarbital, chlorpropamide, and chlorophenoxy herbicides are classic weak acids where alkalinization increases ionization and limits membrane penetration. EXTRIP bedside resource: EXTRIP is the go-to multidisciplinary reference for dialysis decisions in poisoning, especially when you need evidence-based backup during specialist consultation. We get into how to use it in the chapter.
Holiday Dinner Lit Matters 2: Go Easy on the Gravy
Dietary sodium restriction in chronic heart failure has weaker evidence than many clinicians assume. In this Lit Matters review, a 2024 systematic review and meta-analysis found no clear mortality benefit and raised concern for higher heart-failure hospitalization and worse composite outcomes with strict low-sodium diets. Sodium Restriction in Chronic Heart Failure Common 2-gram dogma: A 2 g/day sodium target is widely recommended in CHF, but the physiologic promise of less fluid retention has not translated into convincing clinical benefit in contemporary data. Systematic review signal: Using PRISMA methods, the authors narrowed roughly 9,000 papers to 9 studies and 2,210 patients, underscoring how thin the high-quality evidence base really is. Mortality outcome uncertainty: Across 8 studies, sodium restriction showed no statistically significant reduction in all-cause mortality, with point estimates drifting toward harm rather than benefit. Hospitalization concern: Heart-failure hospitalization was more common in the sodium-restricted groups, a clinically important signal that challenges routine advice to simply cut salt harder. Composite harm finding: In 3 studies, the combined endpoint of death or readmission favored a more liberal sodium approach, with an odds ratio of 4.12 against restriction. We get into why that effect should still be interpreted cautiously in the episode. Modern therapy contrast: SGLT2 inhibitors remain a cornerstone of guideline-directed heart-failure therapy, highlighting that sodium handling may matter more when modified pharmacologically than through rigid dietary restriction alone.
High Risk Low Prevalence: Orbital Cellulitis
Orbital cellulitis is a postseptal infection that can threaten vision and spread intracranially, while preseptal cellulitis is a different anatomic disease with far lower morbidity. In a painful red eye, sinus or dental symptoms plus orbital red flags should push CT imaging and urgent specialty involvement. Orbital vs Preseptal Cellulitis Postseptal anatomy matters: Orbital cellulitis occurs behind the orbital septum, involving the orbital contents and optic nerve drainage pathways, which is why missed disease can progress to cavernous sinus thrombosis or intracranial abscess. Sinus and dental sources: Sinusitis is the most common cause of orbital cellulitis, especially ethmoid disease in younger children, but dental infection and trauma are important alternative sources clinicians should actively seek. Clinical red flag findings: Pain with eye movement, ophthalmoplegia, vision change, RAPD, diplopia that resolves when the affected eye is closed, and proptosis are the bedside findings that should make orbital cellulitis rise fast on the differential. Subtle proptosis bedside check: A top-down look over the patient's forehead can reveal mild proptosis that is easy to miss straight on. That exam pearl is worth hearing in the episode. Kids carry higher burden: Orbital cellulitis is about 10 times more common in children than adults, and winter or spring presentations fit the URI-driven epidemiology without lowering concern in adults. Diagnosis and Early Management CT is first-line imaging: CT brain and orbits with and without contrast is the go-to test when orbital cellulitis is suspected, with MRI reserved for persistent concern when CT is nondiagnostic. Labs do not decide: CRP, ESR, leukocytosis, and even blood cultures cannot rule in or rule out orbital cellulitis; blood cultures are positive in only about 3% of cases. Intraocular pressure check: When orbital red flags are present, measure intraocular pressure to screen for ocular compartment syndrome, a rarer but vision-threatening complication that changes urgency immediately. Early consultant involvement: These patients need prompt ophthalmology involvement because some require surgical drainage, and neurosurgery may enter the picture when there is intracranial extension. Empiric antibiotic targets: Initial therapy should cover staphylococci, streptococci, and anaerobes; vancomycin plus a broad beta-lactam is a common starting point, with regimen nuances we get into in the chapter. Steroids are not proven: A 2021 Cochrane review found no clear improvement in visual acuity preservation, day-3 pain, or IV antibiotic duration with corticosteroids in orbital cellulitis.
An ENT's Approach to Peritonsillar Abscesses
Peritonsillar abscess is a common deep neck infection marked by unilateral sore throat, trismus, muffled voice, and uvular deviation. The hard parts are confirming abscess versus phlegmon, draining safely near the carotid, and deciding who needs imaging, admission, or ENT follow-up. Peritonsillar Abscess Diagnosis and Management Classic bedside findings: PTA usually declares itself with severe unilateral sore throat, trismus, muffled “hot potato” voice, trouble handling secretions, and uvular deviation away from the affected side. Abscess versus phlegmon: Soft-palate bulging with bogginess suggests a drainable fluid collection, but bilateral tonsillitis makes PTA uncommon enough that imaging should usually confirm the diagnosis. Imaging decision support: Ultrasound can help separate abscess from cellulitis, but performance is operator-dependent; when the exam and POCUS are non-diagnostic, CT with IV contrast is often the practical next step. We get into that imaging judgment in the episode. Steroid-assisted examination: Dexamethasone 10 mg IV can meaningfully reduce inflammation and trismus, and giving it about an hour before re-exam may turn a poor oral exam into an adequate one. Drainage safety anatomy: The superior pole is the usual site, and the carotid lies posterolateral only a short distance away, so depth control matters more than enthusiasm during aspiration or incision. Disposition and follow-up: Airway concern is the key reason to transfer, while stable patients often do well with ED treatment plus antibiotics; adults should still get Otolaryngology follow-up after resolution to exclude occult oropharyngeal carcinoma.
Holiday Dinner Lit Matters 3: Watch out for that figgy pudding
Dietary ingredient claims are usually built on observational data, where association is easy and causation is hard. In holiday desserts, fruit, coffee, and nuts trend toward benefit signals, while alcohol stands out as the ingredient most consistently tied to harm. Holiday Dessert Ingredient Evidence Observational evidence caveat: Most nutrition recommendations here rest on umbrella reviews of observational studies, so the signal is association rather than causation and ingredient-level claims deserve caution. Recipe ingredient mapping: Investigators pulled 178 ingredients from 48 Great British Bake Off holiday dessert recipes and grouped them into 17 categories to compare recurring exposures. Benefit-leaning ingredients: Fruit, coffee, and nuts generated the most associations with reduced disease or death, with cancer, neurologic disease, and cardiovascular outcomes appearing most often. Alcohol harm signal: Alcohol had the highest number of adverse associations, and atrial fibrillation was the one outcome backed by strong convincing evidence rather than the usual weak signal. Sugar and butter uncertainty: Sugar and butter were not convincingly linked to harm because the available associations were rated extremely low evidence, a nuance we put in context in the episode. Diet pattern over ingredient: Single ingredients are a poor proxy for real-world diet quality because recipes vary by amount and combination, so moderation and overall dietary pattern matter more.